-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Foghorn Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
- Foghorn Therapeutics Inc. Return On Equity for the quarter ending June 30, 2024 was 140 %, a 84.8% decline year-over-year.
- Foghorn Therapeutics Inc. annual Return On Equity for 2023 was 189 %.
- Foghorn Therapeutics Inc. annual Return On Equity for 2022 was -301 %, a 203% decline from 2021.
- Foghorn Therapeutics Inc. annual Return On Equity for 2021 was -99.5 %, a 174% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)